m7GpppGpG
m7GpppGpG is an unmodified trinucleotide cap analog with enhancer activity. When incorporated into mRNA, it effectively enhances translational efficiency, stability, and protein expression levels of the mRNA. m7GpppGpG can serve as a standard cap analog for in vitro mRNA synthesis to support antigen generation and presentation by dendritic cells, although its expression efficiency in dendritic cells is 20-fold lower than that of the m7GpppApG cap.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 133608-76-1
- Fòrmula: C31H41N15O25P4
- Peso molecular:1147.64
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Ver todos los productos específicos de isoformas DNA/RNA Synthesis
More
Actividad biológica
m7GpppGpG (10 mM; 2 total hours at 37°C) generates the functional m7GpppGpG cap structure alongside non-functional reversed-capped molecules during in vitro mRNA synthesis, with overall capping efficiency of ~90% under typical conditions[1].
mRNA capped with m7GpppGpG exhibits 20-fold lower translation efficiency in JAWSII murine dendritic cells relative to mRNA capped with m7GpppApG, independent of eIF4E affinity and decapping enzyme resistance[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 133608-76-1
-
Peso molecular 1147.64
-
Fòrmula C31H41N15O25P4
-
SMILES
O=P(O)(OC[C@@H]1[C@@H](OP(O)(OC[C@H]2O[C@@H](N3C(NC(N)=NC4=O)=C4N=C3)[C@H](O)[C@@H]2O)=O)[C@@H](O)[C@H](N5C(NC(N)=NC6=O)=C6N=C5)O1)OP(OP(OC[C@H]7O[C@@H](N8C(NC(N)=N9)=C([N+](C)=C8)C9=O)[C@H](O)[C@@H]7O)([O-])=O)(O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Grudzien-Nogalska E, et al. Synthetic mRNAs with superior translation and stability properties. Methods in molecular biology (Clifton, N.J.). 2013;969:55-72. [Content Brief]
[2]. Uchida S, et al. Nanomedicine-Based Approaches for mRNA Delivery. Molecular pharmaceutics. 2020 Oct 05;17(10):3654-3684. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
m7GpppGpG Related Classifications
HY-145976 Related Classifications
Powered by Bioz